We are committed to redefining healthcare: connecting the best of Health&Care for every provider, for every patient, for everyone. Imagine all the amazing things those two simple words can do.
Innovative Medicine
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
MedTech
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.
Innovating in Health&Care
How Johnson & Johnson is fighting medical counterfeiting
Fake medication and compromised devices are part of a global market that poses a significant threat to the health of patients. Here’s how the company’s Global Brand Protection team helps keep people safe.
What are cataracts?
If you can’t read a screen without jacking up the brightness level or if night driving leaves you seeing fuzzy halos around traffic lights, you may among the 20 million U.S. adults who develops a cataract—the most common cause of vision loss worldwide. Luckily a simple surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.
5 things we now know about atrial fibrillation
More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For Atrial Fibrillation Awareness Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But a number of scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed what kind of prognosis many of these patients will have.
An eye for innovation: helping surgeons see more during spinal operations
With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
Diversity in the OR: 3 barrier-breaking female surgeons share their stories
Only one in 10 orthopedic surgeons in the U.S. are women. Learn how Johnson & Johnson is working to change that stat.
What is low vision?
Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. Learn the facts—plus, the promising treatment innovations that are in the works.
By the numbers: Understanding dry eye disease
For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.
Meet two brothers who are revolutionizing the way scientists develop treatments for cancer
Justin and Colin Farlow share how their next-generation cell and gene therapies are helping Johnson & Johnson in its quest to get in front of cancer.
Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis
They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
“No one would believe me when I suspected I had lung cancer”
Learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.
How Johnson & Johnson is helping build a sense of belonging by investing in student nurses of color
A diverse nursing workforce is a better nursing workforce—one that improves quality of care and patient outcomes for all populations. That’s why Johnson & Johnson has put its support behind two pilot programs aimed at setting nurses up for success on campus and in healthcare settings.
“My family and I volunteer on a floating hospital that delivers medical care”
Lee-Anne James is a Janssen clinical research manager whose home base is Australia. That is, when she and her family aren’t donating their time to Mercy Ships to help treat people who lack access to lifesaving healthcare.